GLP-1 TV · News & media · 5 videos
ABC News
@ABCNews on YouTube ↗ABC News is a YouTube channel of news and media coverage of GLP-1 medications, with 20M subscribers and a verified badge. GLP-1 TV holds 5 of its videos, 1.8M views between them, the newest from Mar 2026.
- Medications covered
- Ozempic (2), Wegovy (2), Mounjaro (1), Zepbound (1)
- Topics that come up most
- Side effects, The trials, Fatigue, Stopping and maintenance, Cost and insurance, Dose change
7:48Ozempic, Mounjaro users talk about changes to family life after weight lossABC NewsDetails3 key moments
This ABC News segment looks at how GLP-1 weight loss drugs are changing appearances, relationships and the body positivity conversation. It opens with Oprah Winfrey stepping down as a Weight Watchers spokesperson after saying she has taken medication to lose weight.
- Side effects mentioned: fatigue
- Who is speaking: News or media
2:371st long term study released on weight loss drug WegovyABC NewsDetails
In this Good Morning America segment, ABC News medical correspondent Dr Jen Sutton discusses new research on Wegovy. She says the study found that patients who kept taking the medication maintained their weight loss after four years.
- Who is speaking: News or media
1:49FDA approves weight loss drug Zepbound to treat sleep apneaABC NewsDetails
In this ABC News segment, medical correspondent Dr Darien Sutton explains that the FDA has approved Zepbound for obstructive sleep apnea. Zepbound was already approved for weight loss.
- Who is speaking: News or media
3:33FDA approves new Wegovy doseABC NewsDetails
In this weekend health roundup from ABC News, medical contributor Dr. Alok Patel covers three headlines. The first is the FDA approval of a higher dose of Wegovy.
- Doses mentioned: 2.4 mg
- Who is speaking: News or media
5:52New research shows Ozempic may help curb alcohol addictionABC NewsDetails3 key moments
This ABC News segment covers early research suggesting that semaglutide, the drug used for weight loss, may also reduce drinking in people with alcohol use disorder. Reporter Ariel Rashev describes a small case study of six people who screened positive for alcohol use disorder.
- Who is speaking: News or media
Where semaglutide costs least today
The three cheapest partner programs for semaglutide, all in per month, checked weekly. Brand Ozempic and compounded versions are different products; each row says which it is.
What each ABC News video covers
The opening line of our summary for each video, most-watched first.
- Ozempic, Mounjaro users talk about changes to family life after weight loss
This ABC News segment looks at how GLP-1 weight loss drugs are changing appearances, relationships and the body positivity conversation.
1.6M views · Mar 2024 - 1st long term study released on weight loss drug Wegovy
In this Good Morning America segment, ABC News medical correspondent Dr Jen Sutton discusses new research on Wegovy.
106K views · May 2024 - FDA approves weight loss drug Zepbound to treat sleep apnea
In this ABC News segment, medical correspondent Dr Darien Sutton explains that the FDA has approved Zepbound for obstructive sleep apnea.
47.1K views · Dec 2024 - FDA approves new Wegovy dose
In this weekend health roundup from ABC News, medical contributor Dr. Alok Patel covers three headlines.
18.2K views · Mar 2026 - New research shows Ozempic may help curb alcohol addiction
This ABC News segment covers early research suggesting that semaglutide, the drug used for weight loss, may also reduce drinking in people with alcohol use disorder.
9.8K views · Dec 2023
Watched them? See what it costs.
Every GLP-1 program we track, ranked by what actually leaves your account.